Purpose: This study was aimed at identifying levels of compliance of patients with metabolic syndrome and the factors influencing their compliance. Methods: Data were collected from patients with metabolic syndrome at K medical center in 2009 using questionnaires. The data were analyzed using ANOVA, t-test, Scheffe test, Pearson correlation, and stepwise multiple regression. Results: The mean score of health behavior compliance was 2.82 (range: 1.43~3.87). Of the factors significantly influencing compliance with health behavior, health perception, exercise efficacy, age and perceived severity explained the 42.8% variance of compliance with health behavior. The factor explaining the highest level of variance was health perception. Conclusion: It is essential for health professionals to consider the aforementioned four factors when developing interventions to increase compliance with health behavior of the patient with metabolic syndrome.
taken from the essential drug list and the database of drugs prices. Standard of treatment of CP developed by Ministry of Health of the Russian Federation was used for calculation of medical care costs. Costs of adverse events were calculated basing on Russian clinical guidelines and database of drugs prices. Disability pensions and disable child care were taken from the Russian Pension Fund database. The cost of orthopedic surgeries was calculated on the basis of RF Government program of state guarantees of free rendering to citizens of medical care. Results: Usage of AbobotulinumtoxinA treatment+standard therapy in whole population of SCP patients in Russia will result in 79,585 RUB/1,473 $ economy compared with OnabotulinumtoxinA+standard therapy, 131,178 RUB/2,429 $ economy compared with standard therapy per one patient for 2 years. This cost reduction is mainly attributed to decrease of number of orthopedic surgeries to the better efficacy of this BTA drug. ConClusions: Inclusion of abobotulinumtoxinA+standard therapy appears to be a cost saving treatment option in the management of spastic cerebral palsy in the Russian Federation compared with onabotulinumtoxinA+standard therapy and standard therapy solely.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.